India's drug regulator has flagged a batch of Abhayrab rabies vaccine as substandard. This finding marks the second time concerns have been raised about counterfeit Abhayrab doses. The government's Central Drugs Laboratory found the vaccine did not meet potency requirements. Significant differences were noted between the sampled product and a reference sample. The regulator is investigating whether the vaccine is spurious under Indian law.

INDIA-RABIESVACCINE/COUNTERFEIT (EXCLUSIVE, PIX):EXCLUSIVE-India flags Abhayrab rabies vaccine batch as substandard, probes if spurious, document shows | India News

INDIA-RABIESVACCINE-COUNTERFEIT:Exclusive-India flags Abhayrab rabies vaccine batch as substandard, probes if spurious, document shows | India News

India’s drug regulator flags Abhayrab rabies vaccine batch after a potency test failure and discrepancies raise concerns over its identity and authenticity.

IIL defends its rabies vaccine amid CDSCO's seizure of misbranded vials from an unlicensed Delhi residence.